View in EDS

The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia.

Saved in:
Bibliographic Details
Title: The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia.
Authors: Nagy P; Global Patient Safety & Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Fowler JC; Global Clinical Development MH and EH, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Rosenbrock H; Neuroscience & Mental Health DR, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Tang W; Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Fu E; Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Fraser A; Global Clinical Development Operations, Boehringer Ingelheim UK Ltd., Bracknell, UK., Dursema H; Global CPS Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Schlichtiger J; Global CPS Mental and Eye Health and EA, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Desch M; Global CPS Mental and Eye Health and EA, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gruenenfelder F; Global Patient Safety & Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2026 May; Vol. 66 (5), pp. e70184.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1552-4604
DOI:10.1002/jcph.70184